Summit Global Investments’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
Summit Global Investments's AGL Position: Q1 2022 in Review
Summit Global Investments sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 1,688 shares — an estimated $1.14M sold.
Summit Global Investments first reported a position in AGL in Q3 2021 and held it in 2 quarters. The position peaked at $1.14M in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.
- Summit Global Investments reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
- Summit Global Investments sold 1,688 Agilon Health shares in Q1 2022, an estimated $1.14M.
- Summit Global Investments first reported a position in Agilon Health in Q3 2021 and held it in 2 quarters.
- Summit Global Investments's Agilon Health position peaked at $1.14M in Q4 2021.
- 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.
Based on Summit Global Investments's 13F filing for Q1 2022, filed 29 Apr 2022.